AI Verdict
GILD has stronger fundamentals based on our AI analysis.
CVS vs GILD Fundamental Comparison
| Metric | CVS | GILD |
|---|---|---|
| Revenue | $100.4B | $7.0B |
| Net Income | $2.9B | $2.0B |
| Net Margin | 2.9% | 29.0% |
| ROE | 3.8% | 8.6% |
| ROA | 1.2% | 3.6% |
| Current Ratio | 0.87x | 1.97x |
| Debt/Equity | 0.78x | 0.94x |
| EPS | $2.30 | $1.61 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
CVS vs GILD: Frequently Asked Questions
Is CVS or GILD the better stock in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), GILD has stronger fundamentals. CVS is graded C (75% confidence) while GILD is graded A (78% confidence). This is not investment advice.
How does CVS compare to GILD fundamentally?
CVS HEALTH Corp has ROE of 3.8% vs GILEAD SCIENCES, INC.'s 8.6%. Net margins are 2.9% vs 29.0% respectively.
Which stock pays higher dividends, CVS or GILD?
CVS has a dividend yield of N/A or no dividend while GILD has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in CVS or GILD for long term?
For long-term investing, consider that CVS has a C grade with 75% confidence, while GILD has a A grade with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about CVS vs GILD?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For CVS vs GILD, the AI consensus favors GILD based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.